Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Jerry

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Immunogenetics|January 1, 1982
Control of HLA-DR antigen gene expression at the pretranslational level: comparison of an HLA-DR-positive B lymphoblastoid cell line and its HLA-DR-negative variantS Loosmore, P Gladstone, D Pious, et al.
American Journal of Clinical Pathology|May 1, 1976
Spindle-cell epithelial thymoma. Fine-structural and tumor lymphocyte observationsT A Seemayer, L M Jerry, L Shapiro, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Malignant melanoma (stage 1): a clinical trial of adjuvant BCG immunotherapyA H Paterson, D Willans, L M Jerry, et al.
Biochemical and Biophysical Research Communications|February 15, 1989
Inhibition of neuroglandular antigen (NGA) glycosylation by phorbol ester in human melanoma cellsV Feyles, W T Dixon, L K Sikora, et al.
Oncology|January 1, 1991
Effects of retinoic acid and bromodeoxyuridine on human melanoma-associated antigen expression in small cell lung carcinoma cellsV Feyles, L K Sikora, R C McGarry, et al.
Clinical Allergy|March 1, 1977
Circulating immune complexes in patients with atopic allergyP O Cano, M Chow, L M Jerry, et al.
Tissue Antigens|August 1, 1982
Changes in HLA-DR antigen expression on cultured human melanoma cells during theophylline treatmentS K Liao, P C Kwong, P B Dent, et al.
International Journal of Cancer|January 15, 1990
Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation moleculeW T Dixon, L K Sikora, D J Demetrick, et al.
Endocrine Research Communications|January 1, 1976
Circulating immune complexes in Graves' diseaseP O Cano, M M Chertman, L M Jerry, et al.
Journal of Surgical Oncology|December 1, 1989
Ocular melanoma in Alberta: a 38 year review pointing to the importance of tumor size and tumor histology as predictors of survivalS Hayton, R Lafreniere, L M Jerry, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Immunogenetics|January 1, 1982
Control of HLA-DR antigen gene expression at the pretranslational level: comparison of an HLA-DR-positive B lymphoblastoid cell line and its HLA-DR-negative variantS Loosmore, P Gladstone, D Pious, et al.
American Journal of Clinical Pathology|May 1, 1976
Spindle-cell epithelial thymoma. Fine-structural and tumor lymphocyte observationsT A Seemayer, L M Jerry, L Shapiro, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Malignant melanoma (stage 1): a clinical trial of adjuvant BCG immunotherapyA H Paterson, D Willans, L M Jerry, et al.
Biochemical and Biophysical Research Communications|February 15, 1989
Inhibition of neuroglandular antigen (NGA) glycosylation by phorbol ester in human melanoma cellsV Feyles, W T Dixon, L K Sikora, et al.
Oncology|January 1, 1991
Effects of retinoic acid and bromodeoxyuridine on human melanoma-associated antigen expression in small cell lung carcinoma cellsV Feyles, L K Sikora, R C McGarry, et al.
Clinical Allergy|March 1, 1977
Circulating immune complexes in patients with atopic allergyP O Cano, M Chow, L M Jerry, et al.
Tissue Antigens|August 1, 1982
Changes in HLA-DR antigen expression on cultured human melanoma cells during theophylline treatmentS K Liao, P C Kwong, P B Dent, et al.
International Journal of Cancer|January 15, 1990
Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation moleculeW T Dixon, L K Sikora, D J Demetrick, et al.
Endocrine Research Communications|January 1, 1976
Circulating immune complexes in Graves' diseaseP O Cano, M M Chertman, L M Jerry, et al.
Journal of Surgical Oncology|December 1, 1989
Ocular melanoma in Alberta: a 38 year review pointing to the importance of tumor size and tumor histology as predictors of survivalS Hayton, R Lafreniere, L M Jerry, et al.
Pageof 6